Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.CGH.2023.05.028 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background & Aims: Gastric intestinal metaplasia (GIM) is associated with a higher risk of noncardia intestinal gastric adenocarcinoma (GA). The aim of this study was to estimate lifetime benefits, complications, and cost-effectiveness of GIM surveillance using esophagogastroduodenoscopy (EGD). Methods: We developed a semi-Markov microsimulation model of patients with incidentally detected GIM, to compare the effectiveness of EGD surveillance with no surveillance at 10-year, 5-year, 3-year, 2-year, and 1-year intervals. We modeled a simulated cohort of 1,000,000 US individuals aged 50 with incidental GIM. Outcome measures were lifetime GA incidence, mortality, number of EGDs, complications, undiscounted life-years gained, and incremental cost-effectiveness ratio with a willingness-to-pay threshold of $100,000/quality-adjusted life-year (QALY). Results: In the absence of surveillance, the model simulated 32.0 lifetime GA cases and 23.0 lifetime GA deaths per 1000 individuals with GIM, respectively. Among surveilled individuals, simulated lifetime GA incidence (per 1000) decreased with shorter surveillance intervals (10-year to 1-year, 11.2–6.1) as did GA mortality (7.4–3.6). Compared with no surveillance, all modeled surveillance intervals yielded greater life expectancy (87–190 undiscounted life-years gained per 1000); 5-year surveillance provided the greatest number of life-years gained per EGD performed and was the cost-effective strategy ($40,706/QALY). In individuals with risk factors of family history of GA or anatomically extensive, incomplete-type GIM intensified 3-year surveillance was cost-effective (incremental cost-effectiveness ratio $28,156/QALY and $87,020/QALY, respectively). Conclusions: Using microsimulation modeling, surveillance of incidentally detected GIM every 5 years is associated with reduced GA incidence/mortality and is cost-effective from a health care sector perspective. Real-world studies evaluating the impact of GIM surveillance on GA incidence and mortality in the United States are needed.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Thiruvengadam, Nikhil R. | Hombre |
Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos |
| 2 | Gupta, Shashank | - |
Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos |
| 3 | Buller, Seth | Hombre |
Loma Linda University School of Medicine - Estados Unidos
Loma Linda Univ - Estados Unidos |
| 4 | Awad, Imad | Hombre |
Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos |
| 5 | Gandhi, Devika | - |
Loma Linda University Health - Estados Unidos
Loma Linda Univ Hlth - Estados Unidos |
| 6 | Ibarra, Allison | Mujer |
University of California, San Diego - Estados Unidos
Univ Calif San Diego - Estados Unidos |
| 7 | Latorre, Gonzalo | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 8 | RIQUELME-PEREZ, ARNOLDO JAVIER | Hombre |
Pontificia Universidad Católica de Chile - Chile
Núcleo Milenio de Sociomedicina - Chile Ctr Prevenc & Control Canc CECAN - Chile |
| 9 | Kochman, Michael L. | Hombre |
University of Pennsylvania Perelman School of Medicine - Estados Unidos
Perelman Sch Med - Estados Unidos |
| 10 | Cote, Gregory | Hombre |
Oregon Health & Science University - Estados Unidos
Oregon Hlth & Sci Univ - Estados Unidos |
| 11 | Shah, Shailja C. | - |
University of California, San Diego - Estados Unidos
VA San Diego Healthcare System - Estados Unidos Univ Calif San Diego - Estados Unidos Vet Affairs San Diego Healthcare Syst - Estados Unidos |
| 12 | Saumoy, Monica | Mujer |
Penn Medicine Princeton Medical Center - Estados Unidos
Penn Med Princeton Med Ctr - Estados Unidos |
| Fuente |
|---|
| NIH |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| National Institutes of Health |
| Pontificia Universidad Católica de Chile |
| European Commission |
| European Union |
| Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias |
| Horizon 2020 Framework Programme |
| U.S. Department of Veterans Affairs |
| American Gastroenterological Association |
| Chilean Agency of Research and Development |
| Arnoldo Riquelme |
| Shashank Gupta |
| Allison Ibarra |
| Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP |
| Concurso de politicas publicas 2022 Pontificia Universidad Catolica de Chile |
| Veterans Affairs Career Development Award |
| Chilean Agency of Research and Development Grant FONDECYT |
| American Gastroenterological Association Research Scholar Award |
| Agradecimiento |
|---|
| Funding Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union’s Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de políticas públicas 2022 Pontificia Universidad Católica de Chile. |
| Funding Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union’s Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de políticas públicas 2022 Pontificia Universidad Católica de Chile. |
| Shailja C. Shah is supported by a Veterans Affairs Career Development Award (ICX002027A), an American Gastroenterological Association Research Scholar Award, and NIH P30 DK120515. Arnoldo Riquelme, Gonzalo Latorre, and Shailja C. Shah are supported by the Chilean Agency of Research and Development Grant FONDECYT 1230504. Arnoldo Riquelme is supported by the Chilean Agency of Research and Development Grant FONIS SA1 life-years gained 9I0188, FONDAP 152220002, and European Union's Horizon 2020 research and innovation program grant agreement No. 825832 and Concurso de politicas publicas 2022 Pontificia Universidad Catolica de Chile. |